The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
November 26th 2024
Amgen’s MariTide achieved up to 20% average weight loss at 52 weeks without hitting a plateau in individuals with obesity or overweight.
November 16th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Is Hormone Therapy Dangerous for Women with Existing Heart Risk?
Researchers from the University of Michigan School of Public Health reported last month in the Archives of Internal Medicine that hormone therapy may produce adverse heart health effects even in women who begin treatment within the recommended timeframe post-menopause.
Antimalarial Treatment Prevents Diabetes in Arthritis Patients
November 26th 2008While obesity, hypertension, and diabetes have always shared connections, every now and then, scientists manage to make some of the unlikeliest connections. As it turns out, Geisinger Health System researchers found that "antimalarial medication may prevent the onset of diabetes in patients with rheumatoid arthritis."
Trimming Fast Food Advertising would Cut Back Child Obesity, Study Says
According to a new study published in the November issue of the Journal of Law and Economics, childhood obesity could be reduced by up to 18% by banning fast food advertisements in the United States.
Metformin May Be Linked to Lower Risk of Death from Cardiovascular Disease
A meta-analysis of 40 previously published studies conducted by Elizabeth Selvin, PhD, MPH, of the Johns Hopkins Bloomberg School of Public Health, and colleagues has found that treatment with the diabetes drug metformin may be associated with a lower risk of death from cardiovascular disease.